MAC Clinical Research logo

MAC Clinical Research

Improving quality of life

312 employees · est. 2002 · Blackpool, United Kingdom

VS
Prilenia logo

Prilenia

Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.

57 employees · est. 2018 · Boston, United States

MAC Clinical Research is the older company (2002 vs 2018); MAC Clinical Research is the larger of the two.

Side-by-Side Comparison

MAC Clinical Research Prilenia
Founded
2002 older 2018
Headquarters
Blackpool, United Kingdom Boston, United States
Employees
312 larger 57
Industry
Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $115.50M
Funding Rounds
Not tracked yet 3
Services
Not tracked yet Developing treatments for neurodegenerative diseases, Clinical research, Drug discovery and development
Target Customers
Not tracked yet Patients with neurodegenerative diseases, Families affected by Huntington's Disease and ALS, Medical researchers and healthcare professionals
Taxonomy
Clinical Research, Neuroscience, Clinical Trials, Therapeutic Areas, Pharmaceutical, Dermatology, Cognition, Patient Recruitment, Regulatory Affairs, Vendor Management, Global Clinical Supplies, MHRA Accredited Phase 1 Unit, Early And Late Phase Trials, Biopharmaceutical Clinical-stage Biotech Company, Neurodegenerative Disorders, Neurodevelopmental Disorders, Pridopidine, Movement Disorders, Huntington’s Disease, ALS, Phase 3 Clinical Trial, Phase 2/3 Clinical Trial, Dr. Michael Hayden, Biotech Industry Veteran, Drug Development, Global R&D, Naarden, The Netherlands, Herzliya, Israel
Website
macplc.com prilenia.com
MAC Clinical Research logo

About MAC Clinical Research

MAC Clinical Research is a Contract Research Organisation (CRO) dedicated to conducting full-service global clinical trials for leading pharmaceutical and biotech companies. With a broad range of clinical research capabilities, including a Phase 1 Unit accredited by MHRA, the company specializes in...

Prilenia logo

About Prilenia

Prilenia, founded in 2018, is a promising clinical-stage biotech company advancing the landscape of treatments for neurodegenerative and neurodevelopmental disorders. With headquarters in the United States, and operations spanning Naarden, the Netherlands, Herzliya, Israel, and Boston, MA, Prilenia...

We will tell you when either one moves

BounceWatch watches MAC Clinical Research and Prilenia for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MAC Clinical Research and Prilenia — by email.

Frequently Asked Questions

MAC Clinical Research — Improving quality of life. Prilenia — Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MAC Clinical Research has raised undisclosed funding while Prilenia has raised $115.50M.
MAC Clinical Research and Prilenia operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MAC Clinical Research with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MAC Clinical Research on 10 Nov 2024, and Prilenia on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy